Drug Profile
Research programme: Haemophilus influenza vaccines - Biological Mimetics
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Biological Mimetics
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemophilus infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Haemophilus-infections(Prevention) in USA (Parenteral)
- 04 Jul 2016 Early research in Haemophilus infections (Prevention) in USA (Parenteral)